Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Patient Activation to Address Chronic Pain and Opioid Management in Primary Care [NA]
Clinical trial completed with results posted, investigating patient activation strategies for chronic pain and opioid management in primary …
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route [Phase 1]
Phase 1 trial assessing abuse potential and safety of CL-108 tablets in opioid-experienced, non-dependent recreational drug users; completed…
-
FDA approval · 2019-10-13FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for ketorolac tromethamine filed by Sandoz Inc under an approved ANDA.
-
FDA approval · 2019-10-11FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for a generic oxycodone hydrochloride and acetaminophen product (Oxycodone and Acetaminophen) manufa…
-
FDA approval · 2019-10-11FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for tramadol hydrochloride submitted by Sun Pharmaceutical Industries, Inc. This action expands/…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approves a supplemental application for Hydrocodone Bitartrate and Acetaminophen (PAI Pharma), authorizing continued marketing of this a…
-
FDA approval · 2019-10-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for hydrocodone bitartrate and acetaminophen. This action adds or updates t…
-
FDA label_change · 2019-10-11FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approves a supplemental application for butorphanol tartrate from Hospira, indicating changes to the product labeling for the generic.
-
FDA approval · 2019-10-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen by SpecGx LLC (ANDA) under a supplemental approval.
-
FDA approval · 2019-10-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application for KVK-Tech's hydrocodone bitartrate and acetaminophen product, authorizing changes under an approv…
-
FDA approval · 2019-10-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Aurolife Pharma, LLC)
The FDA approved a supplemental application for a generic hydrocodone bitartrate and acetaminophen product by Aurolife Pharma, LLC.
-
FDA approval · 2019-10-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen submitted by Elite Laboratories, Inc. This action updat…
-
FDA approval · 2019-10-11FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for Methadone Hydrochloride by VistaPharm, LLC.
-
FDA approval · 2019-10-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for a generic hydrocodone bitartrate and acetaminophen product from SpecGx LLC. The action concerns …
-
FDA approval · 2019-10-10FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the pentazocine hydrochloride and naloxone hydrochloride combination product, continuing its ava…
-
FDA approval · 2019-10-10FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen from Amneal Pharmaceuticals of New York LLC under t…
-
FDA approval · 2019-10-09FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application from Apotex Corp. for butorphanol tartrate.
-
FDA approval · 2019-10-09FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for a generic methadone hydrochloride product from Hikma Pharmaceuticals USA Inc., granting marketin…
-
FDA approval · 2019-10-09FDA Approved: PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental ANDA for pentazocine hydrochloride and naloxone hydrochloride from Lupin Pharmaceuticals, indicating regulatory …
-
FDA approval · 2019-10-09FDA Approved: CELECOXIB — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Celecoxib submitted by Actavis Pharma, Inc.
-
FDA approval · 2019-10-09FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for buprenorphine from Sun Pharmaceutical Industries, granting approval of the generic product.
-
FDA approval · 2019-10-09FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a supplemental application for buprenorphine hydrochloride, indicating regulatory clearance for the generic product from PAI Ho…
-
FDA approval · 2019-10-09FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Pentazocine and Naloxone from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2019-10-09FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for METHADONE HYDROCHLORIDE by Hikma Pharmaceuticals USA Inc., granting approval for a supplemental …
-
FDA approval · 2019-10-07FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for MS CONTIN (morphine sulfate) submitted by Rhodes Pharmaceuticals L.P.